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What inspired you to rise to the challenge of 
confronting age-related diseases?
Ageing is arguably the most complex biological 
process, and is thus an enormous intellectual 
challenge. When I started my research career, 
colleagues told me: ‘you suffer from ageing, 
you don’t study it – this is useless’. I found this 
a challenge. In less than 30 years, this view has 
been completely overturned. With biological 
interventions, we can now extend life in many 
animals – in some species up to five times their 
normal lifespan. The goal now is to ensure that 
those extra years are lived in good health. 
In humans, progress in hygiene, lifestyle, food 
and classical medicine causes a continuous 
increase in life expectancy of up to three 
months per year. Healthy life expectancy, 
however, increases much more slowly. If this 
discrepancy is not dealt with, quality of life for 
older people will decline and health service 
costs will soon spiral out of control. Intervening 
to slow the ageing process as the common 
underlying cause of all age-related diseases is 
the only real hope there is.
The strong link between chronic disease 
and old age has been widely acknowledged, 
but research on how to combat this issue is 
lacking. Why is this? 
Primarily because ageing biology is such a 
young science. With good justification, society 
is cautious in redirecting funds towards the 
search for a ‘fountain of youth’, which still 
does not sound like a safe investment strategy. 
However, as ageing biology begins to deliver on 
its promises, the funding situation is improving. 
For instance, in my native country, Germany, 
there was not a single chair in ageing in 2000, 
but now there are three or four institutes 
devoted to understanding this area of research. 
Scientists will now need to show that their work 
can lead to interventions that extend healthy 
life expectancy in humans, especially in those 
that are most vulnerable to rapid ageing and 
the early development of age-related diseases, 
disabilities and cognitive decline. 
What is cellular senescence? How does this 
mechanism lead to chronic disease, frailty and 
other age-related health problems?
Cellular senescence is a response to 
irreparable DNA damage that causes a 
permanent block in cell division. As long as this 
block works, a cell with damaged DNA cannot 
proliferate to generate a tumour. However, cells 
cannot just stop dividing, so the senescence 
response also triggers many other changes 
in the way cells behave. Importantly, they 
generate free radicals and many other potent 
signalling molecules, including those that 
induce inflammation. These signals change the 
behaviour of surrounding cells, making some 
of them senescent as well and redirecting the 
functions of others. Thus, senescence limits 
tissue regenerative capacity, causes chronic 
systemic inflammation and changes function in 
both senescent and non-senescent cells.
Your research group has made world-
leading discoveries about telomeres. Can you 
introduce your studies on this topic?
When telomere shortening became prominent 
as a cause of cellular senescence it was 
known that telomeric DNA must be lost with 
time because of the so-called end replication 
problem – an intrinsic inability of the DNA 
replication machinery to copy a DNA strand 
to its very end. The interpretation was that 
telomeres would be cellular counters or 
clocks, stopping cell proliferation after a fixed 
number of divisions in order to limit the risk of 
tumour proliferation.
At the time, I wanted to confirm that there were 
really two different ‘types’ of ageing: stress-
induced ageing in non-dividing cells, and inborn 
and pre-programmed ageing in dividing cells. 
Much to our surprise, we found that stressed 
cells lost their telomeres much faster, with the 
end replication problem being only a minor 
contribution to total telomere loss. Thus, we 
showed telomeres to be much more functional 
than a simple mechanical clock; namely, a 
‘sentinel’ measuring the risk of DNA damage 
and raising the alarm accordingly.
Is there potential for your research to lead 
to the development of chronic inflammation 
prevention strategies? 
Having shown chronic inflammation to be a 
causal mechanism for accelerated ageing, we 
are, of course, thinking about the possibility of 
anti-inflammatory interventions in fast-ageing 
humans. It is well established that some of 
us age more slowly than others. Could anti-
inflammatories help those on the ‘fast track’? 
The problem is that all anti-inflammatories in 
use have very serious side effects if taken long 
term. New, safer drugs are needed.
Professor Thomas von Zglinicki discusses 
how recent strides in biomedical research 
may improve the health and wellbeing of a 
global ageing population
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CELL BIOLOGY
THE SOCIETAL AND economic burdens 
that come with an ageing global community 
are some of the most challenging issues we 
are confronted with today. People may be 
living longer than ever before but, as age-
related illnesses cause individuals to lose 
their independence, available resources are 
spread ever more thinly. To ease this burden, 
biomedical researchers are investigating ways 
to ensure that ageing individuals stay healthy 
for longer. 
Unfortunately, effective treatments against 
many age-associated conditions have 
proven difficult to develop, due in part to the 
complex nature of the processes underlying 
neurodegeneration and cellular ageing. In 
fact, treating co-morbid diseases individually 
has been shown to have little positive impact 
on overall health. Taking a different approach, 
biomedical scientists are now setting their 
sights on understanding the underlying 
biological mechanism of cellular ageing itself. 
As scientists begin to reveal mechanistic 
insights, the reality of effective interventions 
against age-related conditions as a collective is 
getting tantalisingly nearer.              
At Newcastle University, UK, Professor Thomas 
von Zglinicki’s lab has been at the forefront 
of several major breakthroughs that have 
profoundly affected how ageing is understood. 
His research points toward long-suspected 
chronic, non-microbial inflammation as the 
prime candidate behind a broad range of 
age-related disorders such as heart disease, 
stroke, cancers and arthritis. However, it is the 
underlying cause of this chronic inflammation 
that is of real concern.
TRIMMING TELOMERES
Over time, evidence has emerged pointing 
toward cellular senescence – a permanent 
arrest of cell division when a normally replicating 
cell encounters DNA damage – as a main 
driver of numerous age-related pathologies. 
Telomeres are lengths of non-coding DNA found 
at the end of each chromosome that act as a 
buffer to protect the integrity of the genetic code 
during replication. It was originally thought that 
telomeres are shortened step by step within 
each cell division by a constant molecular 
mechanism. When telomeres get too short, they 
are recognised as damaged DNA by the cell and 
trigger a signal that induces cell senescence 
or, in some cases, cell death. It appeared from 
existing evidence that telomere loss had similar 
characteristics to a regular clock ticking down to 
the end of a cell’s ability to replicate.
The results of Zglinicki’s research conflict 
with this longstanding picture, showing for 
the first time that DNA replication is not the 
only determinant of telomere loss. His team 
assumed, based on current knowledge, that 
using oxidative stress to induce cellular 
senescence would cause cell division to stop 
before telomeres were significantly sheared off.
Although cell division was soon halted, the rate 
of telomere loss actually increased, thereby 
indicating that telomere shortening is affected 
by oxidative damage. In short, DNA repair is 
less efficient in telomeres than elsewhere 
in the genome such that oxidative damage 
speeds up telomere shortening. Rather than 
a countdown to the end of cell proliferation 
as previously thought, telomere loss could be 
viewed as a measuring stick to assess the risk of 
DNA damage. 
Zglinicki’s lab was the first to propose and 
test the hypothesis that the extent of telomere 
shortening could be used as a biomarker for 
ageing and the risk of developing age-related 
disease. The researchers measured telomere 
length in people with various age-related 
conditions, such as cerebrovascular disease 
and strokes, and compared the results to the 
lengths of telomeres in healthy individuals. 
While the results in large cohorts supported the 
theory, the prognostic power was not significant 
enough to be used accurately in individuals to 
define biological age or foretell the outlook of 
health for the future.  
CIRCULUS VITIOSUS
Though telomere shortening may not be the 
accurate biomarker one might hope for, it 
provides a key to unlocking the pathology of 
accelerated ageing. Zglinicki’s lab has found 
the first evidence of a dynamic feedback loop 
characterising the relationship between cellular 
senescence and chronic inflammation. 
This circulus vitiosus, or vicious circle, starts 
when telomeres become too short, triggering 
a DNA damage response that causes cellular 
senescence. As a result, a gene known as 
CDKN1A is activated causing mitochondrial 
dysfunction and the production of reactive 
oxygen species and of signalling peptides like 
IL-1 and IL-6 that cause inflammation. Reactive 
oxygen species cause more DNA damage which 
spurs on the damage response, and so the 
circle continues. 
Recently, Zglinicki’s lab investigated the effects 
of this feedback loop in mice to determine 
whether chronic low-grade inflammation 
accelerates the accumulation of senescent 
Research at Newcastle University’s Institute for Ageing is 
beginning to unlock the complex processes behind ageing, 
revealing for the first time the biological machinery that leads to 
chronic age-related diseases and disabilities
A vicious cycle
A human metaphase (spread chromosomes) and an intact nucleus (upper left corner) showing telomeres 
(red) at the ends of chromosomes (blue). 
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cells, and if these cells in turn aggravate 
chronic inflammation. Genetically engineered 
to produce enhanced inflammatory signals, 
Zglinicki’s team found that the mice aged 
faster than their normal counterparts, who 
lived twice as long. The researchers showed 
that the inflammation signals trigger the 
production of oxygen free radicals to induce 
DNA damage that generated senescence 
signalling. This signalling led to more 
inflammatory signals and the increased 
release of oxygen free radicals. 
INTERVENTION ON THE HORIZON
Although ageing and age-related conditions 
in humans have long been associated with 
chronic inflammation, the research carried 
out by Zglinicki’s team provides the first 
mechanistic explanation of this relationship, 
and has even provided a starting point from 
which to explore potential interventions. Anti-
inflammatories may have had no beneficial 
effects for healthy mice but, for those with 
enhanced inflammation, the cellular signs of 
accelerated ageing came to a halt. Although 
long-term use of existing anti-inflammatories 
has serious side effects, they at least provide 
a crucial platform for the development of 
interventions for individuals ageing faster 
than normal. Ageing is an extraordinarily 
complex process but as biomedical research 
continues to unravel its mysteries, the reality 
of prolonging lifespans and maintaining quality 
of life becomes ever nearer.
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Human cells with cytoskeleton (red) and nuclei (blue) 
showing DNA damage foci (green).
Young (left) and senescent (right) human cells (same 
magnification). Nuclei in blue, intact mitochondria in 
young cells (high membrane potential) in red/yellow,  
dysfunctional mitochondria (low membrane potential) in 
senescent cells in green.
Images (above, far left and below) 
courtesy of Glyn Nelson, Gabriele Saretzki, 
Joao Passos.
A senescent human cell with a central 
nucleus (black) showing telomeres (red) 
and DNA damage foci (blue), many of which 
are co-localised with telomeres (white).
In the cytoplasm, intact mitochondria 
are stained red, while the majority of 
mitochondria shows up as a green stain, 
indicating that they are dysfunctional 
in senescence.
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